Chilling in the Utes stadium
Christine and Sam’s CoDEPT manuscript published in ACS Medicinal Chemistry Letters
Complementation Dependent Enzyme Prodrug Therapy Enables Targeted Activation of Prodrug on HER2-Positive Cancer Cells
https://pubs.acs.org/doi/full/10.1021/acsmedchemlett.2c00394
Sun Jin and Morgan’s paper published in Nature Communications
Vaccinated and finally all back together!
Keith’s manuscript on Fab-CHP conjugates to treat Rheumatoid Arthritis published in Bioconjugate Chemistry
Conjugation of collagen-hybridizing peptides (CHPs) to antibody fragments can improve treatment localization to sites of denatured collagen, potentially limiting on-target effects. Check it out!
Keith is awarded the University Graduate Research Fellowship
Congratulations to Keith Arlotta for receiving funding through the University of Utah Graduate School!
Publication! WIREs Nanomedicine and Nanobiotechnology – Antibody and antibody derivatives as cancer therapeutics
In-depth review of the current state of therapeutic anti-cancer antibodies and antibody derivatives. This review acts as a guide, detailing the effects of specific modifications on antibody function, stability, and half-life.
https://wires.onlinelibrary.wiley.com/doi/full/10.1002/wnan.1556
Sam receives support through UROP
Congrats to Sam Hatch for receiving funding through the University of Utah Undergraduate Research Opportunity Program.
First paper on Target-Engaged Complementation published in Scientific Reports
A Tri-part Protein Complementation System Using Antibody-Small Peptide Fusions Enables Homogeneous Immunoassays. Scientific Reports (2017) 7:8186
Scholarship! Sun Jin received a Skaggs Research Fellowship
Congratulations to Sun Jin Kim (bottom right) as one of four graduate students to receive a Skaggs Research Fellowship.
Much thanks to the College of Pharmacy and the ALSAM Foundation.
